Data story · ASPS 2005–2024
The Tummy Tuck
Explosion
For most of the 2000s and 2010s, the tummy tuck was cosmetic surgery's reliable middle child. Then it grew 75% in four years. No other major procedure has seen anything like it.
$8,005
Avg surgeon
fee (2023)
$3B
Estimated
annual market
The pre-recession peak (148K in 2007). The long plateau (106K–130K from 2008–2019). Then the explosion: 98K in 2020 to 171K in 2024 — 75% growth in four years. The 2007 record that held for 15 years was shattered by 2022.
What changed? Remote work gave patients recovery time they couldn't take before. GLP-1 drugs (Ozempic, Wegovy) created a surge of patients with excess skin after weight loss. And pandemic psychology lowered the decision threshold.
Surgeon fees climbed steadily from $4,402 in 2005 to $6,154 in 2020. Then came the extraordinary 2023 jump: $6,531 to $8,005 in a single year — a 23% increase. At 170K+ procedures and $8K+ per surgery, the surgeon-fee market alone is $1.37 billion.
$8,005
Avg surgeon fee
2023
+82%
Fee increase
2005 to 2023
$1.37B
Surgeon-fee
market (est.)
Avg surgeon fee Total expenditure ($M)
The 40–54 age group consistently accounts for the largest share: 41–49% of all tummy tucks. The 30–39 group adds another 27–36%. Together, three out of four tummy tucks go to women in the mommy makeover demographic. The 40–54 share has been growing — from 41% to 49% — while the 30–39 share has dropped from 34% to 27%.
40–54 30–39 20–29
The under-30 tummy tuck patient is vanishing. The 20–29 share dropped from 10% to 4%, and in absolute numbers from 12,000 to 6,000. Tummy tucks are pregnancy-driven and age-driven — not fashion-driven.
15–25 million Americans have taken GLP-1 drugs. ~60% are women. Of those who lose 30+ pounds, 20–40% will have excess skin significant enough to consider surgery. The primary procedure? The tummy tuck. Even at conservative estimates, that's a pipeline of 1–2 million potential patients.
10–20% → Growing GLP-1 patients as share
of tummy tuck consults
2–4 yrs → Pipeline Time from starting medication
to reaching the OR
200K+ → By 2028 Projected annual
tummy tuck volume
+30K
estimated additional annual
tummy tucks from GLP-1 pipeline
by 2028
The Pacific region (California, Oregon, Washington) consistently accounts for the largest share at 28–30%. The South has been gaining share, reflecting Florida's rise as a cosmetic surgery destination. The Midwest has been declining.
1
The tummy tuck grew 75% in four years.
From 98K (2020) to 171K (2024). No other major cosmetic procedure has seen growth like this. The 2007 record that held for 15 years was shattered.
2
Surgeon fees jumped 23% in a single year.
$6,531 to $8,005 between 2022 and 2023. Demand pressure and medical inflation combined for the biggest fee spike in the dataset.
3
Three out of four tummy tucks go to women 30–54.
The demographic has been remarkably stable for 20 years. This is a pregnancy-driven, age-driven procedure — not a trend.
4
Remote work removed the biggest practical barrier.
Tummy tucks require 2–4 weeks of serious recovery. WFH made that possible without burning all your PTO.
5
The GLP-1 wave hasn't hit yet.
Patients starting Ozempic/Wegovy in 2023–2024 will reach operating rooms in 2025–2028. The pipeline could push volume past 200K annually.